Trial intelligence / Profile preview

Exploratory pharmacokinetic study of Rikkunshito (TJ-43) in healthy volunteers

jRCT1080221759Phase 1

Sponsor
Tsumura & Co.
Start
Apr 2012
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of rikkunshito, sponsored by Tsumura & Co. Primary endpoint: Primary pharmacokinetic endpoints.

02

Drugs

rikkunshito

Beyond the preview

Go deeper on jRCT1080221759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080221759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call